79 transactions on file (1 open-market purchase and 4 open-market sales).
4 open-market sales by BIIB insiders, between Feb 2, 2026 and Aug 4, 2026. A sale made under a trading plan agreed months earlier is not the same event as one decided that week, and the filing itself says which.
Discretionary. The box was on the form and was not ticked. The sale was made at the prevailing price without a pre-arranged plan behind it.
Planned (10b5-1). The filer ticked the Form 4's 10b5-1 box: the sale ran under a trading plan adopted before the trade, so it is a schedule executing rather than a view taken this week.
Not stated. The filing does not say. Either it predates the April 2023 checkbox, or nothing has re-read it since. This tab will not guess which of the two above it was.
The 1 open-market purchase on file carry no plan label. The box can be ticked on a buy, and labelling one would qualify the rarer and more informative of the two signals.
| Date | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-04 | Minor Lloyd Director Open-market salePlanned (10b5-1) | Open-market sale Planned (10b5-1) | −593 | $200.96 | −119.17K | 2,689 |
| 2026-08-03 | Minor Lloyd Director Open-market salePlanned (10b5-1) | Open-market sale Planned (10b5-1) | −593 | $203.34 | −120.58K | 3,282 |
| 2026-06-09 | Patolawala Monish D Director Grant / award | Grant / award | +1,505 | $0.00 | +0 | 5,215 |
| 2026-06-09 | HAWKINS WILLIAM A Director Grant / award | Grant / award | +1,505 | $0.00 | +0 | 10,365 |
| 2026-06-09 | Rowinsky Eric K Director Grant / award | Grant / award | +1,505 | $0.00 | +0 | 25,844 |
74 more transactions are on Measure
| Insider | Role | On Sep 12, 2025 | Now | Change | Sold | Shape |
|---|---|---|---|---|---|---|
| Minor LloydDirector | Director | 3,875 | 2,689 | −30.61% | $239.75K$239.75K on a plan | |
| Murphy NicoleHead of Pharm Ops and Tech | Head of Pharm Ops and Tech | 19,608.0408 | 19,611.0408 | +0.02% | - | |
| Singhal PriyaHead of Development | Head of Development | 7,019.1428 | 8,043.1428 | +14.59% | $665.66K$665.66K on a plan |
Each person’s holding as they reported it after each open-market trade, over the last twelve months. It counts one class of stock and excludes grants, option exercises and shares withheld for tax, so a stake can fall here while somebody’s total holding does not. Since April 2023 a Form 4 states whether a trade ran under a pre-arranged 10b5-1 plan; an older one does not, and those dollars read “not stated” rather than being counted either way.
The assistant answers from what BIIB has actually filed: 19 annual reports filed with the SEC, 79 Form 4 filings from the last year, 13F positions from the 1 tracked investor who hold it and 6 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.
Pressing one answers it here, from BIIB's filings and figures. One a day without an account; a free account has its own, and no card.
See every Form 4 BIIB insiders have filed, not the latest few.
Ten seconds, no card, and nothing to cancel.
Source
From SEC Form 4 filings, filed by officers, directors and 10%-owners within two business days of a transaction. “Indirect” holdings (a trust, an LLC, a family member) are included and not distinguished from direct ones in this table.
Past transactions say nothing about future ones, and none of this is investment advice.
See who bought, not who was handed shares
Every Form 4 BIIB insiders file, not just the latest handful, with vesting and tax withholding struck out so what's left reads as a decision.
Every filingMeasure
Follow the investors who hold it
Each stake priced at the quarter it was filed, and diffed against the quarter before: who added, who trimmed, who left.
Every position they holdMeasure
Ask what a run of filings adds up to
Whether this is one decision or a pattern, and how it compares with BIIB's own history of insider activity.
Free, no card, and it does not expire.